Utility of 18-FDG-PET Scanning in Lymphoma by WHO Classification
Reviewer: M. Kara Bucci, MD
The Abramson Cancer Center of the University of Pennsylvania
Last Modified: December 8, 2001
Presenter: Rebecca L. Elstrom
18-FDG-PET scanning is an important imaging modality in the staging and monitoring of many malignancies, including lymphoma. Some tumors, however, do not have the high glucose uptake needed for 18-FDG uptake, and are therefore not well imaged by PET. In order to assess whether the histologic subtype of a lymphoma is related to its visibility by PET imaging, this retrospective analysis of PET scans was performed at the University of Pennsylvania. The author's assessed PET positivity of newly diagnosed and untreated relapsed lymphoma by WHO classification of the tumors.
Materials and Methods
Of >600 PET scans performed on patients with lymphoma, 155 cases had
pathologic data available for correlation.
Jun 11, 2013 - For Medicare beneficiaries with non-small-cell lung cancer, demographic differences in the rates of positron emission tomography scan use persisted from 1998 to 2007, according to research published in the June issue of Radiology.